Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb 6;77(3):656-668.e5.
doi: 10.1016/j.molcel.2020.01.012. Epub 2020 Jan 30.

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation

Affiliations
Free article

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation

Yi-Lynn Liang et al. Mol Cell. .
Free article

Abstract

Class B G protein-coupled receptors (GPCRs) are important therapeutic targets for major diseases. Here, we present structures of peptide and Gs-bound pituitary adenylate cyclase-activating peptide, PAC1 receptor, and corticotropin-releasing factor (CRF), (CRF1) receptor. Together with recently solved structures, these provide coverage of the major class B GPCR subfamilies. Diverse orientations of the extracellular domain to the receptor core in different receptors are at least partially dependent on evolutionary conservation in the structure and nature of peptide interactions. Differences in peptide interactions to the receptor core also influence the interlinked TM2-TM1-TM6/ECL3/TM7 domain, and this is likely important in their diverse signaling. However, common conformational reorganization of ECL2, linked to reorganization of ICL2, modulates G protein contacts. Comparison between receptors reveals ICL2 as a key domain forming dynamic G protein interactions in a receptor- and ligand-specific manner. This work advances our understanding of class B GPCR activation and Gs coupling.

Keywords: G protein-coupled receptor; agonist efficacy; class B GPCR; corticotropin-releasing factor; cryoelectron microscopy; pituitary adenylate cyclase-activating peptide; receptor activation.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests The authors declare no competing interests.

Comment in

Publication types

MeSH terms